Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03501992 · ClinicalTrials.gov registry record · NA
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 9,242
- Enrollment target
NCT03501992: Completed NA study, sponsored by Mayo Clinic.
NCT03501992 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 9,242 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (559% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03501992, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 9,242 participants
- Enrollment target
Study Summary
Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been disappointingly low and lags behind other adolescent vaccines. This study seeks to test interventions targeting health care system, provider, and patient factors to improve the population uptake of the HPV vaccine.
Primary Outcome
The outcome measure was the proportion of empaneled, HPV-vaccine-dose eligible males and females in the study step who received the dose of HPV vaccine dose due by the end of the study step.
Interventions
- BEHAVIORAL Audit-and-feedback
- BEHAVIORAL Current care
- BEHAVIORAL Reminder-recall
- BEHAVIORAL Combined reminder-recall and audit-and-feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,242 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
What the finished NCT03501992 record still lists
NCT03501992 is an interventional study that assigns participants to a tested intervention. Its 9,242 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (559% higher).
The record links to 0 conditions, and to 4 interventions - of which Audit-and-feedback is the first listed.
NCT03501992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03501992 about?
NCT03501992 is a clinical study titled "Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination". Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been disappointingly low and lags behind other adolescent vaccines. This study seeks to test interventions targeting health ...
What is the current status of trial NCT03501992?
This trial is currently completed. It is a NA study. The enrollment target is 9,242 participants. The study started on 2018-04-01. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT03501992?
The interventions under investigation include: Audit-and-feedback (BEHAVIORAL), Current care (BEHAVIORAL), Reminder-recall (BEHAVIORAL), Combined reminder-recall and audit-and-feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03501992?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03501992's enrollment target sits among peer trials
9,242 17th of 2000 higher than 1,984 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI